So, combined use of AFP and ultrasound can increase the rate of HCC detection, but it also increases the costs and the false-positive rate from 2.9% (ultrasound alone) or 5.0% (AFP alone) to 7.5% (combined) (Zhang and Yang, 1999). Here, AFP is linked to hepatocellular carcinoma.